x
Visit our new Mobile Website next time you access NetDania with your mobile device

SAREPTA THERAPEUTICS INC. - COMMON STOCK

136.04
07-19:59:59 GMT
+1.00
+0.74%
ISIN:N/A

Figures - SAREPTA THERAPEUTICS INC. - COMMON STOCK

Open
135.10
Close
135.04
Year Change
41.08
Year % Change
+41.08%
52 Week High
159.89
52 Week Low
55.25
Volume
2003305
Inc. Vol
67530

News - SAREPTA THERAPEUTICS INC. - COMMON STOCK

08-06:45 GMT
Real Madrid Versus Bayern Munich UCL Preview And Lineup: Ancelotti Makes Huge Tactical Jig
Source: Forbes World, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
BayWa Slips To Loss In Q1 On Weak Revenues; Confirms FY24 Outlook
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
RingCentral (RNG) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
GEA Q1 Profit Rises; Confirms FY24 Outlook
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
Henkel Q1 Group Sales Down 5.2% - Quick Facts
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
Continental AG Slips To Q1 Loss On Weak Sales; Sees Earnings Growth Ahead, Confirms FY24 View
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
Marqeta (MQ) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
LANXESS Posts Loss From Cont. Ops. In Q1; Sales Down 15.4%
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
CompuGroup Medical Q1 Adj. Earnings Rise, Revenues Down; Backs FY24 Outlook
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:26 GMT
This Magnificent Artificial Intelligence (AI) Stock Is Now in the $2 Trillion Club
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:02 GMT
Meet The Swiss Start-Up Bringing Medicines To Lower Income Nations
Source: Forbes World, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-06:02 GMT
The Important Difference Between Generative AI And AGI
Source: Forbes World, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:59 GMT
Wynn Resorts (WYNN) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:59 GMT
European Shares To Open Mostly Lower On Rate Worries, Gaza Ceasefire Uncertainty
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:59 GMT
Evonik Q1 Profit Surges, Sales Down; Sees Sequentially Stable Adj. EBITDA In Q2; Backs FY24 View
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:49 GMT
HSBC Upgrades Cognex (CGNX)
Source: NASDAQ Stocks, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:45 GMT
Biden Administration Halted Bomb Shipments To Israel Over Rafah Invasion Concerns, Reports Say
Source: Forbes World, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:42 GMT
Biohacking Beauty: Trend Or Breakthrough?
Source: Forbes World, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:31 GMT
Siemens Energy Turns To Profit In Q2; Backs FY24 Profit View, Lifts Revenue Growth Forecast
Source: NASDAQ US Markets, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
08-05:24 GMT
US revokes licences for sales of chips to Huawei
Source: BBC US-Canada, Symbol: SAREPTA THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38895.63
20.39
0.05%
5191.08
2.19
0.04%
18106.61
3.5
0.02%
62456.40
22.4
0.04%
18518.01
20.5
0.11%
38266.88
-459.98
-1.19%
3131.79
-15.95
-0.51%
8354.18
-0.27
0.00%
18374.99
-110.36
-0.60%
7810.19
1.23
0.02%
22334.75
32.25
0.14%
2315.32
0.17
0.01%
82.53
-0.543
-0.65%
1.07461
-0.00036
-0.03%
155.245
0.473
0.31%
1.24909
-0.00107
-0.09%
0.65777
-0.00107
-0.16%
1.37539
0.00207
0.15%
166.82800
0.448
0.27%
0.86030
0.00045
0.05%
193.91900
0.43
0.22%
0.90878
0.00033
0.04%
0.97672
0.00004
0.00%
0.59930
-0.00033
-0.06%
105.49300
0.114
0.11%
Top Gainers
Name
Last
+/-
%
0.07
0.04
146.67%
0.01
0.00
84.62%
5.02
2.12
73.10%
2.07
0.74
55.64%
0.26
0.09
54.04%
3.33
1.03
44.78%
1.16
0.35
42.38%
0.08
0.02
42.29%
1.16
0.30
35.44%
1.10
0.28
34.16%
Top Losers
Name
Last
+/-
%
0.04
-0.05
-54.26%
0.03
-0.03
-49.15%
0.06
-0.05
-47.52%
0.01
-0.01
-45.95%
2.85
-2.40
-45.71%
0.04
-0.04
-43.75%
0.50
-0.35
-41.59%
0.03
-0.02
-36.67%
0.27
-0.15
-35.56%
0.02
-0.01
-33.33%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy